Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of DOK6 mRNA | CTD | PMID:29097150 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Estradiol] results in increased expression of DOK6 mRNA | CTD | PMID:32741896 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Dok6 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:21394737 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Dok6 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Dok6 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DOK6 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DOK6 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DOK6 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | increases expression | ISO | DOK6 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of DOK6 mRNA | CTD | PMID:30616060 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in decreased methylation of DOK6 gene | CTD | PMID:31601247 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of DOK6 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of DOK6 mRNA | CTD | PMID:21641981 and PMID:22100608 | aflatoxin B1 | decreases methylation | ISO | DOK6 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of DOK6 intron | CTD | PMID:30157460 | aflatoxin B1 | affects response to substance | ISO | DOK6 (Homo sapiens) | 6480464 | DOK6 gene SNP affects the susceptibility to Aflatoxin B1 | CTD | PMID:25622337 | Aflatoxin B2 alpha | increases methylation | ISO | DOK6 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of DOK6 intron | CTD | PMID:30157460 | antirheumatic drug | increases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of DOK6 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of DOK6 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of DOK6 mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases methylation | ISO | DOK6 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of DOK6 exon and Benzo(a)pyrene results in increased methylation of DOK6 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | ISO | DOK6 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of DOK6 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of DOK6 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of DOK6 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of DOK6 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DOK6 mRNA | CTD | PMID:29097150 | cadmium atom | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOK6 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOK6 mRNA | CTD | PMID:35301059 | CGP 52608 | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to DOK6 gene] | CTD | PMID:28238834 | copper(II) sulfate | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of DOK6 mRNA | CTD | PMID:19549813 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of DOK6 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of DOK6 mRNA | CTD | PMID:25562108 | dorsomorphin | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOK6 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | entinostat results in decreased expression of DOK6 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | Dok6 (Mus musculus) | 6480464 | Ethanol results in increased expression of DOK6 mRNA | CTD | PMID:30319688 | fulvestrant | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of DOK6 gene and [bisphenol S co-treated with Fulvestrant] results in decreased methylation of DOK6 gene | CTD | PMID:31601247 | fulvestrant | affects methylation | ISO | DOK6 (Homo sapiens) | 6480464 | Fulvestrant affects the methylation of DOK6 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of DOK6 mRNA | CTD | PMID:33387578 | irinotecan | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Irinotecan results in decreased expression of DOK6 mRNA | CTD | PMID:20185912 | lead(0) | affects expression | ISO | DOK6 (Homo sapiens) | 6480464 | Lead affects the expression of DOK6 mRNA | CTD | PMID:28903495 | leflunomide | increases expression | ISO | DOK6 (Homo sapiens) | 6480464 | leflunomide results in increased expression of DOK6 mRNA | CTD | PMID:28988120 | methotrexate | increases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of DOK6 mRNA | CTD | PMID:24449571 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of DOK6 gene | CTD | PMID:35440735 | paracetamol | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of DOK6 mRNA | CTD | PMID:22230336 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of DOK6 mRNA | CTD | PMID:32680482 | PCB138 | multiple interactions | ISO | Dok6 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorohexanesulfonic acid | increases expression | ISO | Dok6 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of DOK6 mRNA | CTD | PMID:37995155 | quercetin | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of DOK6 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOK6 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of DOK6 mRNA | CTD | PMID:23806026 | sunitinib | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of DOK6 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of DOK6 mRNA | CTD | PMID:33359661 | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Estradiol] results in increased expression of DOK6 mRNA | CTD | PMID:32741896 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of DOK6 mRNA | CTD | PMID:33387578 | triclosan | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of DOK6 mRNA | CTD | PMID:30510588 | valproic acid | decreases methylation | ISO | DOK6 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of DOK6 gene | CTD | PMID:29154799 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of DOK6 mRNA | CTD | PMID:29427782 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of DOK6 mRNA | CTD | PMID:29427782 | valproic acid | affects expression | ISO | DOK6 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of DOK6 mRNA | CTD | PMID:25979313 | vorinostat | multiple interactions | ISO | DOK6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DOK6 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | DOK6 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of DOK6 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | DOK6 (Homo sapiens) | 6480464 | vorinostat results in increased expression of DOK6 mRNA | CTD | PMID:26272509 | |